✦ LIBER ✦

2 Does an “autoimmune” profile affect the severity of chronic hepatitis C? Results of an Italian survey

✍ Scribed by Tommaso Stroffolini; Guido Colloredo; Giovanni Battista Gaeta; Aurelio Sonzogni; Stefano Angeletti; Massimo Marignani; Giuseppe Pasquale; Giovanna Venezia; Antonio Craxi; Piero Almasio

Book ID: 119631714
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 159 KB
Volume: 35
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(03)90033-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does an ‘autoimmune’ profile affect the

Does an ‘autoimmune’ profile affect the severity of chronic hepatitis C? Results of an Italian survey

✍ T. Stroffolini; G. Colloredo; G.B. Gaeta; A. Sonzogni; S. Angeletti; M. Marignan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Does an ‘autoimmune’ profile affect the

Does an ‘autoimmune’ profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey

✍ T. Stroffolini; G. Colloredo; G. B. Gaeta; A. Sonzogni; S. Angeletti; M. Marigna 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

[629] THE INFLUENCE OF OBESITY AND DIABE

[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP)

✍ M. Persico; M. Masarone; L. Cimino; B. Fimiani; N. Passariello; C. Coppola; G. R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Lymphoblastoid interferon alfa-n1 improv

Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial

✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l